WHITE OAK, Md.--(BUSINESS WIRE)--The Food and Drug Administration’s (FDA) Office of Counterterrorism and Emerging Threats (OCET) has awarded a contract worth over $1.78M to Siemens Government ...
The FDA’s Center for Biologics Evaluation and Research (CBER) granted NanoMosaic’s request for an Advanced Manufacturing Technology (AMT) designation for its Nanoneedle technology for multiplex ...
Domestic manufacturing can improve quality oversight by reducing foreign inspection gaps and enabling early FDA engagement ...
(RTTNews) - Vericel Corporation (VCEL) announced that the U.S. FDA has approved commercial manufacturing of MACI at its new state-of-the-art cell therapy facility in Burlington, Massachusetts. The ...
Beginning January 1, 2026, the company's collagen production will operate out of MPM Medical's 100,000 sq. ft. FDA-registered facility in Mesquite, Texas. The expansion includes advanced collagen ...
Tony Lakavage, executive vice president and head of Global External Affairs at the US Pharmacopeia (USP), outlines the key ...
Manufacturing’s future is inextricably linked with robotic advancement. Organizations embracing these transformative ...
Enables Potential MACI Commercialization Outside of the U.S. CAMBRIDGE, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results